What is diabetic ketoacidosis (DKA), how is it diagnosed, and how is it managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetic Ketoacidosis: Diagnosis and Management

Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes characterized by insulin deficiency leading to hyperglycemia, ketosis, and metabolic acidosis, requiring immediate treatment with fluid resuscitation, insulin therapy, and electrolyte replacement to prevent mortality. 1

Definition and Pathophysiology

DKA results from absolute or relative insulin deficiency with concurrent elevation of counterregulatory hormones, causing:

  • Hyperglycemia (though not always present in euglycemic DKA)
  • Ketone body production
  • Metabolic acidosis
  • Dehydration and electrolyte imbalances

Diagnostic Criteria

According to the American Diabetes Association, DKA diagnosis requires all of the following criteria 2, 1:

  • Blood glucose >250 mg/dL (though ~10% present with euglycemic DKA with glucose <200 mg/dL)
  • Arterial pH <7.3
  • Serum bicarbonate <15 mEq/L
  • Moderate ketonemia or ketonuria

Severity Classification

Parameter Mild Moderate Severe
Arterial pH 7.25-7.30 7.00-7.24 <7.00
Bicarbonate (mEq/L) 15-18 10-14 <10
Mental Status Alert Alert/drowsy Stupor/coma

Clinical Presentation

Common symptoms include:

  • Polyuria and polydipsia (most common)
  • Nausea, vomiting, abdominal pain
  • Weight loss
  • Severe fatigue
  • Dyspnea
  • Altered mental status in severe cases 3

Diagnostic Evaluation

Essential Laboratory Tests:

  • Blood glucose
  • Arterial blood gas or venous pH
  • Serum bicarbonate
  • Anion gap calculation
  • Serum ketones (preferred) or urine ketones
  • Electrolytes (sodium, potassium, chloride)
  • BUN and creatinine
  • Complete blood count with differential
  • HbA1c

Additional Tests to Consider:

  • Phosphate levels
  • ECG (to assess for cardiac abnormalities)
  • Urinalysis
  • Blood and urine cultures (if infection suspected)
  • Chest radiography
  • Amylase, lipase (if pancreatitis suspected)
  • Hepatic transaminases
  • Troponin, creatine kinase (if cardiac involvement suspected) 3

Management

1. Fluid Resuscitation

  • Initial fluid resuscitation with isotonic saline (0.9% NaCl)
  • Adults: 15-20 mL/kg/hr during first hour (typically 1-1.5 L)
  • After initial resuscitation, continue IV fluids at 4-14 mL/kg/hr
  • Switch to 0.45% saline when serum sodium is normal or elevated 1

2. Insulin Therapy

  • Start with IV insulin infusion at 0.1 units/kg/hr
  • Continue until resolution of ketoacidosis (pH >7.3, bicarbonate ≥18 mEq/L)
  • If glucose falls below 200 mg/dL before ketoacidosis resolves, add dextrose to IV fluids while continuing insulin 1

3. Electrolyte Replacement

  • Potassium: Start replacement when serum potassium <5.2 mEq/L and patient is producing urine
    • Typical replacement: 20-30 mEq potassium in each liter of IV fluid
    • Hold insulin if potassium <3.3 mEq/L until corrected
  • Phosphate: Consider replacement if serum phosphate <1.0 mg/dL or if cardiac dysfunction, anemia, or respiratory depression occurs
  • Bicarbonate: Generally not recommended except in severe acidosis (pH <6.9) with hemodynamic instability 1

4. Transition to Subcutaneous Insulin

  • Begin subcutaneous insulin 2-4 hours before discontinuing IV insulin
  • Calculate total daily insulin requirement based on IV insulin rate (approximately 36 units/24 hours if IV rate was 1.5 units/hour)
  • Continue IV insulin for 2-4 hours after first subcutaneous dose to prevent rebound hyperglycemia 1

Monitoring During Treatment

  • Hourly monitoring of:
    • Vital signs
    • Neurological status
    • Blood glucose
    • Fluid input/output
  • Every 2-4 hours:
    • Electrolytes
    • BUN, creatinine
    • Venous pH 1

Resolution Criteria

DKA is considered resolved when:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3 1

Complications to Monitor

Cerebral Edema

  • More common in children
  • Prevention: avoid too rapid correction of serum osmolality (not exceeding 3 mOsm/kg/h)
  • In pediatric patients, limit initial vascular expansion to 50 ml/kg in first 4 hours 1

Hypoglycemia

  • Monitor glucose frequently
  • Add dextrose to IV fluids when glucose <200 mg/dL 1

Hypokalemia

  • Monitor potassium levels closely
  • Replace as needed 1

Prevention of Recurrence

  • Identify and treat underlying causes (infection, missed insulin, etc.)
  • Patient education on:
    • Diabetes self-management
    • Blood glucose monitoring
    • Sick-day management
    • When to seek medical attention
    • Proper insulin administration
  • Schedule follow-up appointment prior to discharge 1

Special Considerations

Euglycemic DKA

  • Can occur with SGLT2 inhibitor use, pregnancy, reduced food intake, alcohol use, or liver failure
  • Diagnosis requires ketoacidosis with blood glucose <200 mg/dL
  • Management principles remain the same 2

Recurrent DKA

  • Often associated with insulin omission
  • Higher incidence of psychiatric illness, especially depression
  • May require psychological counseling and social support 2

Pregnancy

  • Up to 2% of pregnancies with pregestational diabetes may be complicated by DKA
  • Pregnant patients may present with euglycemic DKA
  • Requires immediate attention due to risk of feto-maternal harm 2

By following this structured approach to diagnosis and management, the mortality rate from DKA can be significantly reduced from the historical 2-5% to lower levels reported by tertiary care centers 2, 4.

References

Guideline

Diabetes Management in Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.